An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.
Ducray F, de Reyniès A, Chinot O, Idbaih A, Figarella-Branger D, Colin C, Karayan-Tapon L, Chneiweiss H, Wager M, Vallette F, Marie Y, Rickman D, Thomas E, Delattre JY, Honnorat J, Sanson M, Berger F.
Ducray F, et al. Among authors: marie y.
Mol Cancer. 2010 Sep 7;9:234. doi: 10.1186/1476-4598-9-234.
Mol Cancer. 2010.
PMID: 20822523
Free PMC article.